Algo version: 0.98b
Senhwa Biosciences Inc is listed at the TWO Exchange
Senhwa Biosciences Inc [6492.TWO]
TWO Sector: Healthcare Industry:Biotechnology

Is Senhwa Biosciences Inc stock a buy?

What Is The Conclusion?

Right now our advanced algorithms say:

Do the analyst corps agree?

Interesting Questions and Easy Answers!

We cannot find any recorded dividends paid in our systems.

Sorry, we do not have any analyst data for this ticker

We cannot find data for Senhwa Biosciences Inc 10 years ago, but if you had invested on Friday 22nd of November 2019 when the price was TWD62.14, you would have made a loss of TWD-16.49 per share or -26.54%

Yes, the average daily trading liquidity for Senhwa Biosciences Inc is TWD678 950 thousand. You should therefore be able to get in and out of your positions relatively fast.

Senhwa Biosciences Inc has no real debt, which is good in periods of high inflation. The company is still not profitable, and high inflation will make it harder to become profitable as costs increase and consumer spending decreases.

We have calculated the inflation risk for Senhwa Biosciences Inc to be medium [0.7 of 1]

US inflation for August 2024 was 0.19%. Over the last 12 months, the US inflation is 2.59%. The 10-year treasury yield that indicates the future interest level is currently 4.41 and is up 0.05 over the last 30 days.